Total Payments
$3,483
2024 Payments
$81.51
Companies
20
Transactions
179
Medicare Patients
6,155
Medicare Billing
$830,273
Payment Breakdown by Category
Food & Beverage$3,426 (98.4%)
Education$56.95 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,426 | 176 | 98.4% |
| Education | $56.95 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,030 | 46 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $699.19 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $340.60 | 13 | $0 (2023) |
| Amgen Inc. | $265.28 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $196.92 | 10 | $0 (2019) |
| PFIZER INC. | $182.28 | 16 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $169.24 | 8 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $129.87 | 6 | $0 (2018) |
| Boston Scientific Corporation | $103.69 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $69.94 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81.51 | 4 | Novartis Pharmaceuticals Corporation ($81.51) |
| 2023 | $239.92 | 12 | Novartis Pharmaceuticals Corporation ($177.68) |
| 2021 | $54.92 | 3 | E.R. Squibb & Sons, L.L.C. ($22.30) |
| 2019 | $1,064 | 41 | Janssen Pharmaceuticals, Inc ($549.98) |
| 2018 | $1,091 | 57 | Janssen Pharmaceuticals, Inc ($277.11) |
| 2017 | $952.03 | 62 | Novartis Pharmaceuticals Corporation ($216.02) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: DIABETES | ||||||
| 06/24/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: Cardiovascular | ||||||
| 06/17/2021 | Bayer HealthCare Pharmaceuticals Inc. | Verquvo (Drug) | Education | In-kind items and services | $14.31 | General |
| Category: Cardio-pulmonary | ||||||
| 02/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Anemia | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.07 | General |
| Category: DIABETES | ||||||
| 09/24/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,377 | 3,308 | $1.2M | $201,393 |
| 2022 | 7 | 1,363 | 3,214 | $1.1M | $196,396 |
| 2021 | 9 | 1,526 | 3,508 | $1.2M | $221,777 |
| 2020 | 10 | 1,889 | 3,472 | $1.3M | $210,709 |
Total Patients
6,155
Total Services
13,502
Medicare Billing
$830,273
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 536 | 1,529 | $840,950 | $165,768 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 594 | 1,408 | $204,160 | $17,870 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $90,727 | $12,038 | 13.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 43 | $7,568 | $3,083 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 43 | $4,644 | $1,526 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 70 | $1,476 | $588.00 | 39.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 19 | 124 | $4,960 | $520.80 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 535 | 1,491 | $820,050 | $160,732 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 604 | 1,405 | $203,725 | $18,023 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $91,724 | $12,980 | 14.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $6,688 | $2,605 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 42 | $4,536 | $1,477 | 32.6% |
| 85610 | Blood test, clotting time | Office | 2022 | 23 | 116 | $4,640 | $491.28 | 10.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 30 | $600.00 | $88.83 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 574 | 1,588 | $873,400 | $179,518 | 20.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 627 | 1,472 | $213,440 | $19,998 | 9.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 85 | 85 | $82,540 | $12,268 | 14.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 71 | $26,625 | $5,522 | 20.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 27 | $4,701 | $1,758 | 37.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 16 | 16 | $2,320 | $1,063 | 45.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 43 | 44 | $4,752 | $890.55 | 18.7% |
| 85610 | Blood test, clotting time | Office | 2021 | 26 | 117 | $4,680 | $501.93 | 10.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 74 | 88 | $1,760 | $258.00 | 14.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 472 | 854 | $469,700 | $86,363 | 18.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 132 | 494 | $180,310 | $33,668 | 18.7% |
About Dr. Steven Siskind, MD
Dr. Steven Siskind, MD is a Cardiovascular Disease healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376542944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Siskind, MD has received a total of $3,483 in payments from pharmaceutical and medical device companies, with $81.51 received in 2024. These payments were reported across 179 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,426).
As a Medicare-enrolled provider, Siskind has provided services to 6,155 Medicare beneficiaries, totaling 13,502 services with total Medicare billing of $830,273. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Manhasset, NY
- Active Since 07/18/2005
- Last Updated 04/02/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1376542944
Products in Payments
- XARELTO (Drug) $1,030
- ENTRESTO (Drug) $468.73
- LEQVIO (Drug) $230.46
- Corlanor (Drug) $227.58
- PRADAXA (Drug) $188.74
- BRILINTA (Drug) $182.51
- JARDIANCE (Drug) $151.86
- ELIQUIS (Drug) $145.56
- PRALUENT (Drug) $145.51
- PRALUENT ALIROCUMAB INJECTION (Biological) $129.87
- CHANTIX (Drug) $106.66
- WATCHMAN (Device) $88.70
- INJECTAFER (Drug) $45.76
- Mitra Clip system (Device) $42.72
- Repatha (Biological) $37.70
- ZIO Patch (Device) $36.02
- Vascepa (Drug) $33.90
- BYSTOLIC (Drug) $30.59
- Edarbi (Drug) $26.40
- MULTAQ (Drug) $23.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Manhasset
Bruce Rutkin, Md, MD
Cardiovascular Disease — Payments: $328,717
Cardiovascular Disease $328,717
Mitchell Weinberg, Md, MD
Cardiovascular Disease — Payments: $163,984
Cardiovascular Disease $163,984
Dr. Perwaiz Meraj, M.d, M.D
Cardiovascular Disease — Payments: $121,905
Cardiovascular Disease $121,905
Dr. Benjamin Hirsh, M.d, M.D
Cardiovascular Disease — Payments: $50,588
Cardiovascular Disease $50,588
Dr. Andrea Mignatti, M.d, M.D
Cardiovascular Disease — Payments: $24,976
Cardiovascular Disease $24,976
Michael Mannino, M.d, M.D
Cardiovascular Disease — Payments: $20,568
Cardiovascular Disease $20,568